Compared to Estimates, Leidos (LDOS) Q1 Earnings: A Look at Key Metrics
Werte in diesem Artikel
For the quarter ended March 2026, Leidos (LDOS) reported revenue of $4.4 billion, up 3.7% over the same period last year. EPS came in at $3.13, compared to $2.97 in the year-ago quarter.The reported revenue represents a surprise of +3.12% over the Zacks Consensus Estimate of $4.27 billion. With the consensus EPS estimate being $2.88, the EPS surprise was +8.56%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Leidos performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Defense: $883 million versus the two-analyst average estimate of $931.98 million.Revenue- Homeland: $816 million versus the two-analyst average estimate of $781.7 million.Revenue- Health: $1.19 billion versus $1.12 billion estimated by two analysts on average.Revenue- Intelligence & Digital: $1.51 billion versus $1.46 billion estimated by two analysts on average.Non-GAAP operating income- Intelligence & Digital: $155 million compared to the $149.92 million average estimate based on two analysts.Non-GAAP operating income- Defense: $73 million versus the two-analyst average estimate of $93.34 million.Non-GAAP operating income- Homeland: $69 million compared to the $75.13 million average estimate based on two analysts.Non-GAAP operating income- Health: $288 million versus the two-analyst average estimate of $250.63 million.View all Key Company Metrics for Leidos here>>>Shares of Leidos have returned -6.7% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Leidos und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Leidos
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Leidos
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
